Conversion to Everolimus in Kidney Transplant Recipients: A Safe and Simple Procedure
- 1 October 2006
- journal article
- conference paper
- Published by Elsevier in Transplantation Proceedings
- Vol. 38 (8) , 2424-2426
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Evolution of Proteinuria After Conversion From Calcineurin Inhibitors (CNI) to Sirolimus (SRL) in Renal Transplant Patients: A Multicenter StudyTransplantation Proceedings, 2005
- Proteinuria Following a Switch from Calcineurin Inhibitors to SirolimusTransplantation, 2005
- Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimusNephrology Dialysis Transplantation, 2005
- Concentration-Controlled Everolimus (Certican): Combination with Reduced Dose Calcineurin InhibitorsTransplantation, 2005
- Rapamycin in patients with chronic renal allograft dysfunctionClinical Transplantation, 2005
- Everolimus and Reduced-Exposure Cyclosporine in de novo Renal-Transplant Recipients: A Three-Year Phase II, Randomized, Multicenter, Open-Label StudyTransplantation, 2004
- Predictors of Success in Conversion from Calcineurin Inhibitor to Sirolimus in Chronic Allograft DysfunctionAmerican Journal of Transplantation, 2004